A growing number of men are turning to testosterone replacement therapy (TRT) in search of renewed vitality, but the surge in prescriptions has raised important questions about whether low testosterone is a genuine medical condition or a marketing invention. As social media influencers and men’s health companies promote the hormone as a cure-all, many are left wondering if they are being sold a solution to a problem they don’t really have.
A Personal Journey into Low Testosterone
Nick Dooley, a 38-year-old train driver, recalls a time when he felt full of life and confidence. However, as he approached his thirties, things began to change. He experienced weight gain and anxiety, which led him to feel like a shadow of his former self. By the time he reached 38, he weighed 22 stone and faced various health challenges. After a private medical examination revealed low testosterone levels and fatty liver disease, he sought advice online, only to find that his NHS doctor dismissed his concerns, stating that his levels were still “within range.”
Frustrated with the NHS’s response, Nick turned to Manual, a men’s health service that has since rebranded as Voy. After two blood tests and a virtual consultation, he began TRT, receiving testosterone cypionate injections three times a week. This treatment, he claims, has transformed his life, alleviating his anxiety and depression and leading to a significant weight loss of 45 kilograms. Today, he not only feels revitalised but also shares his journey as a TRT influencer on social media.
The Rise of Testosterone Culture
Nick’s story is not unique. Across platforms like TikTok, influencers promote the concept of “T-maxxing,” encouraging men to maximise their testosterone levels through both natural and synthetic means. With celebrities like Robbie Williams and Joe Rogan discussing their experiences with TRT, the narrative around testosterone has shifted dramatically. Men are increasingly viewing low testosterone as a crisis of masculinity, spurred on by alarming claims from various corners of society, including politicians.
Channa Jayasena, an NHS endocrinologist, notes that prescriptions for testosterone in the UK surged by 135% from 2021 to 2024, with a notable increase among younger men. This trend has caused concern among medical professionals, who worry that many men may be misdiagnosed and unnecessarily anxious about their hormonal health.
The Controversy Surrounding Diagnosis
The medical community is divided over testosterone deficiency, known as hypogonadism. While some experts argue that low testosterone is widely underdiagnosed, others caution that it may be overdiagnosed, and men are being led to believe they require treatment when they do not. This disparity has resulted in a complex landscape where men grappling with symptoms may be caught in a web of conflicting information.
George, a social care worker from Manchester, shared his struggle to receive a proper diagnosis. Despite experiencing low libido and weight gain, he was initially dismissed by his doctor. After taking an at-home blood test that suggested low testosterone levels, he sought a second opinion and was eventually prescribed TRT. The results were life-changing, restoring his energy and confidence.
Conversely, Will, who faced similar issues, found it difficult to convince doctors of his need for treatment. After a long search, he finally located a TRT clinic that agreed to prescribe him testosterone. “It’s like I was wearing glasses with the wrong prescription; suddenly, all the blurriness lifted,” he explained, illustrating the profound impact of receiving appropriate care.
The Tipping Point: The Role of Men’s Health Companies
The rise of direct-to-consumer men’s health companies like Voy and Hims has reshaped the conversation around testosterone. While these companies have made treatment more accessible, they operate in a grey area; in the UK, advertising testosterone is illegal, but promoting tests for it is not. This loophole has led to an increase in men seeking tests online, often resulting in an overwhelming influx of patients into clinics.
Dr Jeff Foster, a director at Voy, believes that men are frequently failed by the NHS when it comes to hormone-related issues. He argues that there is growing evidence that even marginally low testosterone can lead to significant health benefits when treated. However, the marketing tactics employed by these companies have raised eyebrows. Some claim that the exaggerated prevalence of low testosterone is a ploy to widen their market share and increase profit margins.
Why it Matters
The debate surrounding testosterone replacement therapy is more than just a matter of medical diagnosis; it touches on broader societal issues related to masculinity, mental health, and the medicalisation of normal life. As men navigate a landscape filled with conflicting information, the risks of self-diagnosis and self-treatment loom large. The pressure to conform to ideals of masculinity, compounded by the growing discourse around testosterone, can exacerbate feelings of inadequacy. As the cultural narrative continues to evolve, it is crucial for men to have access to balanced information and appropriate healthcare without the influence of marketing agendas.
